Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Satoshi Osada is active.

Publication


Featured researches published by Satoshi Osada.


Bioscience, Biotechnology, and Biochemistry | 2003

Effect of α, α-dialkyl amino acids on the protease resistance of peptides

Hiroshi Yamaguchi; Hiroaki Kodama; Satoshi Osada; Fumio Kato; Masood Jelokhani-Niaraki; Michio Kondo

A tryptic [EC 3.4.21.4] digestion assay of 2-aminoisobutyric acid (Aib)-containing peptides was carried out to investigate the effect of α,α-dialkyl amino acid residues on the protease resistance. The introduction of Aib residues to the P1′ positions exhibited a 19-fold higher protease resistance than the peptide with Aib residues introduced to the P2 position or the non-Aib peptide. The peptide having Aib residues introduced to the P1′ and P2 positions resulted in complete resistance.


Bioorganic & Medicinal Chemistry | 2010

Fluoroalkene modification of mercaptoacetamide-based histone deacetylase inhibitors.

Satoshi Osada; Satoshi Sano; Mariko Ueyama; Yoshiro Chuman; Hiroaki Kodama; Kazuyasu Sakaguchi

Inhibitors of histone deacetylases (HDAC) are emerging as a promising class of anti-cancer agents. The mercaptoacetoamide-based inhibitors are reported to be less toxic than hydroxamate and are worthy of further consideration. Therefore, we have designed a series of analogs as potential inhibitors of HDACs, in which the mercaptoacetamide group was replaced by (mercaptomethyl)fluoroalkene, and their HDAC inhibitory activity was evaluated. Subnanomolar inhibition was observed for all synthetic compounds.


Bioorganic & Medicinal Chemistry | 2012

Formation of ion-selective channel using cyclic tetrapeptides

Torao Suga; Satoshi Osada; Hiroaki Kodama

It is important for ion channel peptides to have energetic stability and ion-selectivity for development of some medicines. In the present study, our objective was to achieve formation of energetically stable and ion-selective channels in the membrane using cyclic tetrapeptides. We succeeded in formation of energetically stable and ion-selective channels using two cyclic tetrapeptides cyclo(D-Ala-Dap)(2) (Dap; l-2,3-diaminopropionic acid) and cyclo(D-Ala-Glu)(2). The results of ion channel recording suggested that the cationic cyclo(D-Ala-Dap)(2) was resulted in Cl(-) anion-selective and the anionic cyclo(D-Ala-Glu)(2) led to K(+) cation-selective ion channel formation, respectively. This ion selectivity may be attributed to the charge state of peptides. And a low-hydrophobic cyclic tetrapeptide; cyclo(D-Ala-Dap)(2) had a tendency to form stable ion channel compared to more high-hydrophobic ones; cyclo(D-Phe-Lys)(2), cyclo(D-Phe-Dap)(2) and cyclo(D-Ala-Lys)(2). Our findings will shed light on the field of ion channel peptide study, especially cyclic one.


Biochemistry | 2008

Ion-channel formation assisted by electrostatic interhelical interactions in covalently dimerized amphiphilic helical peptides.

Junichi Taira; Masoud Jelokhani-Niaraki; Satoshi Osada; Fumio Kato; Hiroaki Kodama

An ultimate goal of synthetic ion-channel peptide design is to construct stable and functional ion-conducting pores. It is expected that specific interhelical interactions would facilitate the association of helices in phospholipid membranes and the successive helix-bundle formation. In the present study, we rationally designed helix-bundle ion channels using the synthetic hybrid peptide K20E20, a disulfide dimer of cationic- and anionic-amphiphilic helices Ac-CGG-(BKBA) 5-NH 2 and Ac-CGG-(BEBA) 5-NH 2. Circular dichroism (CD) measurements in aqueous media implied helix stabilization in the peptide caused by the interhelical electrostatic interactions. In addition, CD spectra recorded in the presence of DPPC liposomes and dye-leakage measurements suggested a high degree of association of peptide monomers in phospholipid membranes as well as high affinities between peptide and lipid bilayers. These features allowed ion-channel formation at extremely low peptide concentrations (as low as 1 nM). According to electrophysiological analyses, stable helix bundles were constructed of six peptide helices by association of three K20E20 molecules. Helix-helix association in lipid membranes, peptide-membrane interactions, and ion-channel formation of K20E20 peptides were all facilitated by intramolecular electrostatic interactions between the helices of the hybrid peptide and were pH-dependent. Conductance through K20E20 ion channels decreased under acidic conditions because of the interruption of the salt bridges.


Materials Science and Engineering: C | 2015

Promotion of cell adhesion by low-molecular-weight hydrogel by Lys based amphiphile

Torao Suga; Satoshi Osada; Takayuki Narita; Yushi Oishi; Hiroaki Kodama

Hydrogels formed by low-molecular hydrogelators have been used as anti-microbial agents and cell-attachment materials. However the biomedical application of low-molecular gelators is slowly progressing compared to the hydrogels formed by polymer hydrogelator that is applied to biomedical application such as tissue engineering and biomedical regions. To obtain a simple molecular model for potent and prospective usage of low-molecular hydrogelators, we designed a Lys-based hydrogelator which was mimic to the poly cationic poly-l-lysine that promotes cells to attach to a plastic plate nonspecifically. The gel-coating led to cause 10-fold cell attachment compared to no-coating well. Also five-time cells were attached to the well compared to the poly-l-lysine coating. From the competitive assay, these hydrogels could interact with cells through electrostatic interaction between positive charge from -NH3(+) in the hydrogelator and negative charge from substances on the cell surface such as glycosaminoglycans. This strong adhesive ability can be useful for the tissue engineering and molecular glue regions using low-molecular hydrogels in the future.


Journal of Inorganic Biochemistry | 2014

Anti-tumor activities of Au(I) complexed with bisphosphines in HL-60 cells.

Ryo Hayashi; Kazuhiro Nakatsui; Daisuke Sugiyama; Toshiki Kitajima; Nobuhiko Oohara; Masashi Sugiya; Satoshi Osada; Hiroaki Kodama

We found that Au(I) complexed with 2,3-bis(tert-butyl(methyl)phosphino) quinoxaline (10) was a potent anti-tumor agent (half-maximal growth inhibitory concentration, GI50=0.87μM) with broad anti-tumor activity. In particular, the activity of complex 10 was high in tumor cell lines derived from the colon and ovary. Treatment with complex 10 resulted in the apoptosis of HL-60 cells. The ligand for the preparation of complex 10 is commercially available implying that complex 10 might be a good drug candidate for cancer therapy.


International Journal of Peptide Research and Therapeutics | 2010

Peptaibol Derived Helix‐Kink Motif Facilitates Channel Forming of the Artificial α-Aminoisobutyric Acid Rich Helices

Junichi Taira; Mitsukuni Shibue; Satoshi Osada; Hiroaki Kodama

Characteristic motifs have been identified in natural channel forming peptides though critical roles of such motifs are not well understood. In this paper, the helix‐kink motif found in peptaibols was embedded into the α-aminoisobutyric acid (Aib) rich template to explore its roles in peptide structure and ion channel functions. According to circular dichroism studies and single channel measurements, the motif reduced helical contents of peptide whereas ion channel forming was facilitated and conductance value was increased.


Bioorganic & Medicinal Chemistry | 2014

Development of potent antagonists for formyl peptide receptor 1 based on Boc-Phe-D-Leu-Phe-D-Leu-Phe-OH.

Ryo Hayashi; Toshiki Kitajima; Hikaru Mizuguchi; Miki Fujimoto; Aya Yamaguchi; Shuichiro Koga; Yuya Koga; Satoshi Osada; Hiroaki Kodama

While stimulation of formyl peptide receptors (FPRs) on the surface of human neutrophils induces several immune responses, under conditions of continuous activation of the receptor by agonists such as formyl-Met-Leu-Phe-OH (fMLP), neutrophil-dependent tissue damage ensues. Thus, FPR antagonists could be anticipated as drugs for FPR-related disease. In this study, Boc-Phe-D-Leu-Phe-D-Leu-Phe-OH (Boc-FlFlF), one of several FPR subtype selective antagonists, was chosen and the positions at the Phe residues were optimized. We found that substitution with unnatural amino acids resulted in an improvement of two orders of magnitude. The most potent antagonist indicated FPR subtype selectivity at 1 μM. In addition to finding a potent antagonist, the structure-activity trends observed in this study should be valuable in designing a new type of FPR subtype selective antagonist.


Bioorganic & Medicinal Chemistry | 2013

A formyl peptide substituted with a conformationally constrained phenylalanine residue evokes a selective immune response in human neutrophils

Ryo Hayashi; Masaya Miyazaki; Satoshi Osada; Hiroshi Kawasaki; Ichiro Fujita; Yuhei Hamasaki; Hiroaki Kodama

Formyl-Met-Leu-Phe-OH (fMLP) binds to formyl peptide receptors, FPR1 and FPR2, and evokes migration and superoxide anion production in human neutrophils. To obtain a more effective and selective ligand, fMLP analogs in which the Phe residue was substituted with four isomers of cyclopropanephenylalanine were synthesized. While Z-isomer peptides induced both migration and superoxide anion production, E-isomer peptides elicited only chemotaxis. Homologous receptor desensitization experiments revealed that E-isomer peptides bound to FPR2. Although a selective agonist of chemotaxis also binds to FPR2 without increasing intracellular calcium concentration, E-isomer peptide elevated the concentration to the same level as fMLP. Understanding of mechanisms responsible for the selectivity of the reported selective agonists and ∇Phe-substituted analogs should prove useful for revealing the relationship between receptor-ligand interactions and biological responses of human neutrophils.


Advances in Experimental Medicine and Biology | 2009

Synthesis and Biological Activities of Cyclic Peptide, Hymenamide Analogs

Yasuhiro Shiki; Mika Onai; Daisuke Sugiyama; Satoshi Osada; Ichiro Fujita; Hiroaki Kodama

protein tyrosine kinase inhibitor cytotoxicity cytotoxicity protein tyrosine kinase inhibitor Synthesis and Biological Activities of Cyclic Peptide, Hymenamide Analogs Yasuhiro Shiki, Mika Onai, Daisuke Sugiyama, Satoshi Osada, Ichiro Fujita and Hiroaki Kodama Department of Chemistry, Faculty of Science and Engineering, Saga University, Saga 840-8502, Japan; Department of Pediatrics, Faculty of Medicine, Saga University, Saga 849-8501, Japan

Collaboration


Dive into the Satoshi Osada's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Yuhei Hamasaki

Jikei University School of Medicine

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Michio Kondo

National Institute for Environmental Studies

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge